Schizophrenia/Psychosis

In this CME article, familiarize yourself with various pharmacokinetic, pharmacodynamic, and patient-specific factors to review to develop a successful cross-titration plan from one antipsychotic to another.

A new meta-analysis identifies target for improved care in patients with schizophrenia.

Thinking about sex and sleep in schizophrenia: Researchers performed a large cross-sectional study of sex differences in insomnia and cognition in chronic schizophrenia.

Have you had difficulty with differential diagnosis when patients have manic symptoms and psychosis? One doctor discusses the related DSM-5 criteria changes and some of their implications for psychopharmacology.

The glass is half full: reflections on where we are and hope for where we are heading in psychiatry.

Here's why the RAISE study is important and what you need to know to help patients.

The supplemental new drug application of brexpiprazole for the treatment of schizophrenia in pediatric patients aged 13 to 17 received FDA approval.

Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP provide some advice to clinicians on explaining schizophrenia to patients and caregivers to achieve understanding and therapy adherence.

Is cannabis’ effect on schizophrenia being downplayed?

Dr. Sanjai Rao and nurse practitioner Kimberly Garcia explain the barriers patients face in getting treatment with long-acting injectables and how COVID-19 has affected patient care.

Experts discuss the advantages of using the longest-acting injection formulation to treat schizophrenia, and whether there’s a need to discuss LAIs with patients from onset of illness.

Kimberly Garcia, DNP, CRNP, and Sanjai Rao, MD, DFAPA, review the administration frequencies of long acting injectables risperidone, aripiprazole, and paliperidone.

Sanjai Rao, MD, DFAPA, starts a conversation on how to discuss long acting injectables with patients and how to best transition from an oral medication.

Nurse Practitioner Kimberly Garcia and Dr. Sanjai Rao have a discussion on how they treat schizophrenia and highlight the considerations of prescribing long-acting injectables.

Key opinion leaders comment on how to monitor and increase patient treatment adherence to prevent relapse.

Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP, discuss how practitioners diagnose a schizophrenia relapse, and how to discuss relapse with patients.

Kimberly Garcia, DNP, CRNP, explains how widespread schizophrenia is and the challenges and unmet needs of treatment.

What treatment strategies are available to improve the quality of life for older adults who are aging with schizophrenia?

Should we go up? Researchers performed a dose-response meta-analysis of randomized controlled trials in acute phase schizophrenia.

Does clozapine increase the risk of severe COVID-19 infection? Researchers performed a larger register-based cohort study of this association.

Negative symptoms of schizophrenia are associated with higher overall morbidity and decreased functioning. These study results offer hope.

How does schizophrenia as a pathology differ from normal human experience?

Put out your cigarette. Researchers performed a cohort study of the impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder, and bipolar disorder.